Evaluation of Bacillus oleronius as a Biological Indicator for Terminal Sterilization of Large-Volume Parenterals

References

1. 1.↵
   Ministry of Health, Labour and Welfare of Japan. Yueki Working Group Hokokusho. Report from the Working Group of Large-Volume Parenterals, Pharmaceuticals, and Medical Devices committee, dated March 2, 2004 (in Japanese).
2. 2.↵
   Glucose Injection (monograph). Japanese Pharmacopeia 16 (English version).
3. 3.↵
   U.S. Department of Health and Human Services. Di(2-ethylhexyl)phthalate. Report on Carcinogens, 13th Ed.; 2014.
4. 4.↵
   PDA Japan Chapter, Sterile Products GMP Committee Terminal Sterilization Method Guidance Study Group. Sterility assurance of terminal sterilization products based on absolute bioburden method. Pharm. Technol. Japan 2013, 29, 1303–1310.

   OpenUrl
5. 5.↵
   Pharmaceuticals and Medical Devices Agency (PMDA, Japan). Guidance on the Manufacture of Sterile Pharmaceutical Products Produced by Terminal Sterilization, 2012 (Heisei 23).
6. 6.↵
   1. Sasaki T.

   3.1.2. Preparation and purification of spores. In The Methods of Bioburden and Environmental Microorganisms in Accordance with ISO Standard; Japanese Standard Association: Tokyo, Japan, 1996; pp 146–147 (in Japanese).
7. 7.↵
   1. Penna T. C. V.,
   2. Marques M.,
   3. Machoshvili I. A.,
   4. Ishi M.

   The Effect of Composition of Parenteral Solution on the Thermal Resistance of Bacillus stearothermophilus and Bacillus subtilis Spores. Appl. Biochem. Biotechnol. 2002, 98-100, 539–551.

   OpenUrl
8. 8.↵
   1. Gauthier C. A.,
   2. Smith G. M.,
   3. Pflug I. J.

   Effect of phosphate buffer concentration on the heat resistance of Bacillus stearothermophilus spores suspended in parenteral solutions. Appl. Environ. Microbiol. 1978, 36 (3), 457–464.

   OpenUrlAbstract/FREE Full Text
9. 9.↵
   1. Bryland A.,
   2. Broman M.,
   3. Erixon M.,
   4. Klarin B.,
   5. Linden T.,
   6. Friberg H.,
   7. Wieslander A.,
   8. Kjellstrand P.,
   9. Ronco C.,
   10. Carsson O.,
   11. Godaly G.

   Infusion fluids contain glucose degradation products. Intensive Care Med. 2010, 36 (7), 1213–1220.

   OpenUrlCrossRefPubMedWeb of Science
10. 10.↵
    1. Kjellstrand P.,
    2. Erixon M.,
    3. Wieslander A.,
    4. Linden T.,
    5. Martinson E.

    Temperature: the single most important factor for degradation of glucose fluids during storage. Perit. Dial. Int. 2004, 24 (4), 385–391.

    OpenUrlAbstract/FREE Full Text
11. 11.↵
    1. Pflug I. J.,
    2. Evans K. D.

    Carrying out biological qualification, the control operation of moist-heat (steam sterilization) processes for producing sterile pharmaceuticals and medical devices. PDA J. Pharm. Sci. Tech. 2000, 54 (2), 117–135.

    OpenUrl
12. 12.
    1. Murrell W. G.,
    2. Scott W. J.

    The heat resistance of bacterial spores at various water activities. J. Gen. Microbiol. 1966, 43 (3), 411–425.

    OpenUrlCrossRefPubMed
13. 13.
    1. Bhothipaksa K.,
    2. Busta F. F.

    Osmotically induced increase in thermal resistance of heat-sensitive, dipicolinic acid-less spores of Bacillus cereus Ht-8. Appl. Environ. Microbiol. 1978, 35 (4), 800–808.

    OpenUrlAbstract/FREE Full Text
14. 14.
    1. Hachisuka Y.

    Gaho (saikin houshi) no tainetsusei no kiko (Mechanism of heat resistance of bacterial spores). Kagaku to Seibutsu 1980, 18 (11), 731–739 (in Japanese).

    OpenUrl
15. 15.↵
    1. Nishihara T.,
    2. Kanoh Y.,
    3. Uchida Y.,
    4. Kondo M.

    Studies on the bacterial spore coat (10): Role of surface metals in germination of Bacillus megaterium spores. Nihon Saikin-gaku Zashi 1981, 36 (6), 767–774 (in Japanese with English abstract).

    OpenUrl
16. 16.↵
    1. Akers J. E.,
    2. Agalloco J. P.

    A more rational approach for sterile product manufacturing. Pharm. Technol. 2012, 36 (5), s48–s50.

    OpenUrl